Recursion closes on a $121M series C for AI-backed R&D July 16, 2019 By Lee Landenberger No Comments Some new investors pitched in to Recursion Pharmaceuticals Inc.'s $121 million series C financing, adding to the industry's vision of the importance of AI and machine learning.Read More